Evidence map›Paper›PMID 39408722›Full record

ReviewInternational journal of molecular sciences2024

Macrophages in the Context of Muscle Regeneration and Duchenne Muscular Dystrophy.

Francisco Hernandez-Torres, Lidia Matias-Valiente, Virginia Alzas-Gomez, Amelia Eva Aranega

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Stem/progenitor cell-based therapy for Duchenne muscular dystrophy.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francisco Hernandez-TorresDepartment of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0003-1343-8274
Lidia Matias-ValienteMedina Foundation, Technology Park of Health Sciences, 18016 Granada, Spain.
Virginia Alzas-GomezMedina Foundation, Technology Park of Health Sciences, 18016 Granada, Spain.
Amelia Eva AranegaMedina Foundation, Technology Park of Health Sciences, 18016 Granada, Spain.ORCID 0000-0002-0046-9410

Funding

Consejería de Universidad, Investigación e Innovación ProyExcel_00513Duchenne Parent Project Spain DUCHENNE_2018/001Ministerio de Ciencia, Innovación y Universidades PID2022-138163OB-C31
6 · The paper itself

Abstract

Macrophages are essential to muscle regeneration, as they regulate inflammation, carry out phagocytosis, and facilitate tissue repair. These cells exhibit phenotypic switching from pro-inflammatory (M1) to anti-inflammatory (M2) states during muscle repair, influencing myoblast proliferation, differentiation, and myofiber formation. In Duchenne Muscular Dystrophy (DMD), asynchronous muscle injuries disrupt the normal temporal stages of regeneration, leading to fibrosis and failed regeneration. Altered macrophage activity is associated with DMD progression and physiopathology. Gaining insight into the intricate relationship between macrophages and muscle cells is crucial for creating effective therapies aimed at treating this muscle disorder. This review explores the dynamic functions of macrophages in muscle regeneration and their implications in DMD.

Indexed as

MacrophagesMuscle, SkeletalMuscular Dystrophy, DuchenneRegenerationAnimalsCell DifferentiationHumansDuchenne muscular dystrophyinflammationmacrophagesskeletal muscle

Identifiers

PMID39408722
PMCPMC11477283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.